At the same time, of course, pharmaceutical and other organizations are developing the equivalent of application ontologies to support their planning processes in which terms may be reserved, for example, for chemical substances that have not yet been synthesized.The problems identified in the above do not pertain specifically to ontologies and to the role of the general terms therein.